Metastatic breast cancer response after exemestane withdrawal: A case report

SA Bhide, Daniel Rea

Research output: Contribution to journalArticle

8 Citations (Scopus)


A forty-three year old female patient with right sided breast cancer was treated with adjuvant radiotherapy and Tamoxifen. She had a relapse in the right supraclavicular fossa after a disease free period of 12 years. She progressed, after a short period of disease stabilization on Idoxifene followed by a further stable period on Anastrazole. At further disease relapse, she was commenced on Exemestane. After a period of disease stabilization and subsequent disease progression in the right supraclavicular fossa, Exemestane was discontinued. Six weeks later there was a marked regression of the right supraclavicular mass. Withdrawal response to Tamoxifen is well documented. To our knowledge a similar response after Exemestane withdrawal has not been reported in the literature.
Original languageEnglish
Pages (from-to)66-68
Number of pages3
JournalThe Breast
Publication statusPublished - 1 Jan 2004


  • response
  • breast cancer
  • withdrawal
  • metastatic
  • Exemestane


Dive into the research topics of 'Metastatic breast cancer response after exemestane withdrawal: A case report'. Together they form a unique fingerprint.

Cite this